While promising, the technology is still developing, and its effectiveness can be inconsistent
[7] [8] Whilst this reduction in appetite is central to Wegovy's effectiveness, it also introduces a nutritional challenge: when people eat considerably less, they risk consuming insufficient protein
Lipotropics are known to aid in the breakdown of fat in the liver, supporting weight management and liver health
Elevated GH levels subsequently trigger the liver to produce insulin-like growth factor 1 (IGF-1), which mediates many of GH's anabolic effects, including protein synthesis, lipolysis (fat breakdown), and tissue repair
BMJ 29(372):n71 Crocker TF, Lam N, Jordo M, Brundle C, Prescott M, Forster A et al (2023) Risk-of-bias assessment using Cochranes revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review
Heres an example of each